Table 1.
Eligibility Criteria | Random Allocation | Concealed Allocation | Baseline Comparability | Subjects Blinding | Therapist Blinding | Assessor Blinding | Adequate Follow-Up (>85%) | Intention-to-Treat Analysis | Between-Group Comparisons | Points Estimates and Measure of Variability Provided | Total PEDro Score | Sample Size ≥ 50 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mekbib et al. [67] | x | x | x | x | x | x | x | 6/10 | no | ||||
De Rooij et al. [68] | x | x | x | x | x | x | x | x | x | 8/10 | no | ||
Lin et al. [69] | x | x | x | x | x | x | x | x | 7/10 | no | |||
Huang et al. [70] | x | x | x | x | x | x | x | x | 7/10 | no | |||
Ögün et al. [71] | x | x | x | x | x | x | x | x | x | 8/10 | no | ||
Kim et al. [72] | x | x | x | x | x | x | x | 7/10 | no | ||||
Cho et al. [73] | x | x | x | x | x | x | x | 7/10 | no | ||||
Subramanian et al. [74] | x | x | x | x | x | x | x | 7/10 | no | ||||
Lee et al. [75] | x | x | x | x | x | x | x | 7/10 | no | ||||
Subramanian et al. [76] | x | x | x | x | x | x | x | 7/10 | no | ||||
Crosbie et al. [77] | x | x | x | x | x | x | x | x | x | 8/10 | no | ||
Kang et al. [78] | x | x | x | x | x | x | x | x | 7/10 | no |